Equity
AOCI
Gilead Sciences AOCI increased by 8.3% to $39.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 70.5%, from $132.00M to $39.00M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -8.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large negative values often reflect unfavorable currency movements or a decline in the market value of the company's investment portfolio.
Detailed definition
A component of equity that aggregates unrealized gains and losses that are excluded from net income. This typically incl...
Peer comparison
Multinational corporations with significant overseas operations and large cash portfolios are more sensitive to this metric than domestic-only firms.
Metric ID:
aociHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.00M | $74.00M | $83.00M | $73.00M | $87.00M | $98.00M | $2.00M | -$20.00M | $10.00M | $31.00M | $28.00M | $69.00M | $93.00M | $73.00M | $132.00M | $92.00M | -$18.00M | $36.00M | $39.00M |
| QoQ Change | — | +89.7% | +12.2% | -12.0% | +19.2% | +12.6% | -98.0% | <-999% | +150.0% | +210.0% | -9.7% | +146.4% | +34.8% | -21.5% | +80.8% | -30.3% | -119.6% | +300.0% | +8.3% |
| YoY Change | — | — | — | — | +123.1% | +32.4% | -97.6% | -127.4% | -88.5% | -68.4% | >999% | +445.0% | +830.0% | +135.5% | +371.4% | +33.3% | -119.4% | -50.7% | -70.5% |
Range-$20.00M – $132.00M
CAGR+0.0%
Avg YoY Growth+176.6%
Median YoY Growth+32.4%
Current Streak2 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's aoci?
- Gilead Sciences (GILD) reported aoci of $39.00M in Q4 2025.
- How has Gilead Sciences's aoci changed year-over-year?
- Gilead Sciences's aoci decreased by 70.5% year-over-year, from $132.00M to $39.00M.
- What is the long-term trend for Gilead Sciences's aoci?
- Over 5 years (2020 to 2025), Gilead Sciences's aoci has grown at a -8.3% compound annual growth rate (CAGR), from -$60.00M to $39.00M.
- What does aoci mean?
- A bucket for 'paper' gains or losses on investments and currency changes that haven't been finalized yet.